Nektar Therapeutics (NKTR)

NASDAQ · Pharmaceuticals

74.13
+1.46 (+2.01%)
Updated Aug 18, 6:45 PM ET
AI Rating
Buy
Overall Score
64
Trend
68
Momentum
73
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Nektar Therapeutics is trading at $74.13, up 2.01% on the session. The 50 day average sits at $67.67 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 53.5, which reads as neutral, and MACD is bullish crossover. Volume is above average.

The nearest support is around $67.11 with resistance near $73.98, so that band frames the current range. Average daily movement is roughly $2.99, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 68, momentum of 73 and a risk score of 44.

Technical indicators

RSI (14)
53.5
neutral
MACD
1.833
bullish crossover
SMA 20
71.98
SMA 50
67.67
SMA 200
--
unknown
ATR (14)
2.99
avg daily range
Support
67.11
Resistance
73.98
Volume vs 20d
1.23x
above average
Volatility
38.6%
annualised
1 month
+8.90%
3 months
-1.76%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.